Original Articles
Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination
Julie Robichaud, Catherine Côté and Fanny Côté
CMAJ August 09, 2021 cmaj.211212; DOI: https://doi.org/10.1503/cmaj.211212
Julie Robichaud
Departments of Critical Care Medicine and Internal Medicine (Robichaud), Pharmacy (C. Côté) and Internal Medicine (F. Côté), CIUSSS Saguenay-Lac-Saint-Jean, Chicoutimi, Que.
MD PhDCatherine Côté
Departments of Critical Care Medicine and Internal Medicine (Robichaud), Pharmacy (C. Côté) and Internal Medicine (F. Côté), CIUSSS Saguenay-Lac-Saint-Jean, Chicoutimi, Que.
BPharm MSc,Fanny Côté
Departments of Critical Care Medicine and Internal Medicine (Robichaud), Pharmacy (C. Côté) and Internal Medicine (F. Côté), CIUSSS Saguenay-Lac-Saint-Jean, Chicoutimi, Que.
MDIn this issue
Article tools
Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination
Julie Robichaud, Catherine Côté, Fanny Côté
CMAJ Aug 2021, cmaj.211212; DOI: 10.1503/cmaj.211212